Citigroup Inc Novo Nordisk A S Transaction History

Citigroup Inc

$217 Billion
Q3 2025

A detailed history of Citigroup Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Citigroup Inc holds 490,484 shares of NVO stock, worth $23.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

490,484

Previous 1,150,970 57.39%

Holding current value

$23.8 Million

Previous $79.4 Million 65.74%

% of portfolio

0.01%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	SELL	$45.38 - $71.7 $30 Million - $47.4 Million	-660,486 Reduced 57.39%	490,484 $27.2 Million
Q2 2025 Aug 11, 2025	SELL	$58.08 - $81.05 $5.54 Million - $7.74 Million	-95,438 Reduced 7.66%	1,150,970 $79.4 Million
Q1 2025 May 12, 2025	SELL	$69.3 - $90.95 $25.3 Million - $33.2 Million	-365,158 Reduced 22.66%	1,246,408 $86.6 Million
Q4 2024 Feb 12, 2025	BUY	$85.0 - $120.04 $21.5 Million - $30.3 Million	252,412 Added 18.57%	1,611,566 $139 Million
Q3 2024 Nov 12, 2024	BUY	$119.07 - $145.42 $3.42 Million - $4.17 Million	28,707 Added 2.16%	1,359,154 $162 Million

Q2 2024 Aug 12, 2024	BUY	$122.71 - $146.91 $2.72 Million - $3.26 Million	22,164 Added 1.69%	1,330,447 $190 Million
Q1 2024 May 10, 2024	BUY	$102.11 - $135.92 $74.7 Million - $99.4 Million	731,539 Added 126.84%	1,308,283 $168 Million
Q4 2023 Feb 09, 2024	BUY	$87.78 - $105.45 $480,595 - $577,338	5,475 Added 0.96%	576,744 $59.7 Million
Q3 2023 Nov 09, 2023	BUY	$90.94 - $199.54 $28.2 Million - $61.9 Million	310,026 Added 118.67%	571,269 $52 Million
Q2 2023 Aug 10, 2023	BUY	$155.98 - $172.65 $594,127 - $657,623	3,809 Added 1.48%	261,243 $42.3 Million
Q1 2023 May 11, 2023	BUY	$132.34 - $159.14 $708,283 - $851,717	5,352 Added 2.12%	257,434 $41 Million
Q4 2022 Feb 09, 2023	BUY	$102.55 - $135.33 $3.6 Million - $4.75 Million	35,074 Added 16.16%	252,082 $34.1 Million
Q3 2022 Nov 10, 2022	SELL	$95.28 - $116.93 $96,899 - $118,917	-1,017 Reduced 0.47%	217,008 $21.6 Million
Q2 2022 Aug 10, 2022	BUY	$103.24 - $121.81 $5.77 Million - $6.8 Million	55,851 Added 34.44%	218,025 $24.3 Million
Q1 2022 May 12, 2022	BUY	$93.1 - $112.54 $1.4 Million - $1.69 Million	15,040 Added 10.22%	162,174 $18 Million
Q4 2021 Feb 10, 2022	BUY	$95.88 - $117.08 $2.97 Million - $3.63 Million	30,980 Added 26.67%	147,134 $16.5 Million
Q3 2021 Nov 10, 2021	BUY	$84.42 - $106.62 $9.81 Million - $12.4 Million	116,154 New	116,154 $11.2 Million

Others Institutions Holding NVO

# of Institutions

1,693

Shares Held

303M

Call Options Held

25.9M

Put Options Held

43.8M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account